ResearcherFirst Affiliated Hospital of Soochow UniversityNo recent work listed

Suhua Xia

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9491-465X; OpenAlex author ID A5100617520. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: 1 paper

Papers 2

ZNF281 Promotes Growth and Invasion of Pancreatic Cancer Cells by Activating Wnt/β-Catenin Signaling. Last author DOI 10.1007/s10620-017-4611-1 ↗
Clinical implication of Sox9 and activated Akt expression in pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s12032-014-0358-0 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yu Qian · 1 shared paper, 2017 · strength 0.12
- Paper ZNF281 Promotes Growth and Invasion of Pancreatic Cancer Cells by Activating Wnt/β-Catenin Signaling. DOI 10.1007/s10620-017-4611-1 ↗
Yufeng Wu · 1 shared paper, 2015 · strength 0.05
- Paper Clinical implication of Sox9 and activated Akt expression in pancreatic ductal adenocarcinoma. DOI 10.1007/s12032-014-0358-0 ↗
Yizhong Feng · 1 shared paper, 2015 · strength 0.05
- Paper Clinical implication of Sox9 and activated Akt expression in pancreatic ductal adenocarcinoma. DOI 10.1007/s12032-014-0358-0 ↗
Min Tao · 1 shared paper, 2015 · strength 0.05
- Paper Clinical implication of Sox9 and activated Akt expression in pancreatic ductal adenocarcinoma. DOI 10.1007/s12032-014-0358-0 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.